-
Novo Nordisk A/S (NVO $44.27)
- $44.27 P/E (TTM): 12.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Broadcom Inc. (AVGO $422.47)
- $422.47 P/E (TTM): 82.12X Cap: $1.97T
- View AVGO Profile
- View Questions on AVGO
-
Alphabet Inc. (GOOG $384.06)
- $384.06 P/E (TTM): 35.45X Cap: $4.64T
- View GOOG Profile
- View Questions on GOOG
-
Microsoft Corporation (MSFT $410.01)
- $410.01 P/E (TTM): 25.92X Cap: $3.07T
- View MSFT Profile
- View Questions on MSFT
-
NVIDIA Corporation (NVDA $198.55)
- $198.55 P/E (TTM): 40.5X Cap: $4.82T
- View NVDA Profile
- View Questions on NVDA
-
Constellation Software Inc. (CSU $2,447.02)
- $2,447.02 P/E (TTM): 72.88X Cap: $52.36B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
-
Cameco Corporation (CCO $165.64)
- $165.64 P/E (TTM): 181.84X Cap: $70.21B
- View CCO Profile
- View Questions on CCO
-
Celestica Inc. (CLS $584.55)
- $584.55 P/E (TTM): 57.39X Cap: $65.89B
- View CLS Profile
- View Questions on CLS
-
Shopify Inc. Class A Subordinate Voting Shares (SHOP $159.99)
- $159.99 P/E (TTM): 134.78X Cap: $226.09B
- View SHOP Profile
- View Questions on SHOP
- View Reports on SHOP
-
Tesla Inc. (TSLA $398.87)
- $398.87 P/E (TTM): 358.55X Cap: $1.47T
- View TSLA Profile
- View Questions on TSLA
-
Novo Nordisk A/S (NVO $44.27)
- $44.27 P/E (TTM): 12.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
Aritzia Inc. Subordinate Voting Shares (ATZ $141.21)
- $141.21 Cap: $16.10B
- View ATZ Profile
- View Questions on ATZ
- View Reports on ATZ
-
Kraken Robotics Inc. (PNG $7.55)
- $7.55 Cap: $2.37B
- View PNG Profile
- View Questions on PNG
- View Reports on PNG
-
ASML Holding N.V. (ASML $1,428.01)
- $1,428.01 P/E (TTM): 49.25X Cap: $534.26B
- View ASML Profile
- View Questions on ASML
-
Robinhood Markets Inc. (HOOD $77.73)
- $77.73 P/E (TTM): 36.11X Cap: $68.93B
- View HOOD Profile
- View Questions on HOOD
-
Brookfield Corporation Class A Limited Voting Shares (BN $61.80)
- $61.80 P/E (TTM): 82.26X Cap: $137B
- View BN Profile
- View Questions on BN
-
Nebius Group N.V. (NBIS $174.94)
- $174.94 Cap: $44.79B
- View NBIS Profile
- View Questions on NBIS
Q: My TFSA portfolio has done exceptionally well in large part due to the invaluable information and coaching provided by Peter and the rest of the 5i team since 2013. Thank you very much for helping to build our intergenerational legacy.
I plan to use a fraction of the assets in my TFSA to set up a high-growth, moderate high-risk concentrated 10 stock six-digit sub-portfolio with a 10 year time-frame and hoping for a 5-10 fold target. The idea is to select the best high conviction durable names, maximize capital gains compounding, and minimize dividend drag such as US withholding tax in the TFSA. With the help of my chatbot assistant, it looks like a base case of 17-25% annualized is required to reach the 5-10x target, even with periods of significant drawdowns and bull cases. Obviously stock selection and staying invested for the long term are key.
My initial tentative selection of 10 stocks NVDA, ASML, MSFT, AVGO, NBIS, GOOG, TSLA, CCO, NVO, and SHOP with weightings ranging from 6% to 16%
Could you please critique my strategy and the stocks selected. Suggest improvements including alternative names to consider as replacements that you feel might work better.
If you were creating such a portfolio for yourself which 10 names would you select.
I plan to use a fraction of the assets in my TFSA to set up a high-growth, moderate high-risk concentrated 10 stock six-digit sub-portfolio with a 10 year time-frame and hoping for a 5-10 fold target. The idea is to select the best high conviction durable names, maximize capital gains compounding, and minimize dividend drag such as US withholding tax in the TFSA. With the help of my chatbot assistant, it looks like a base case of 17-25% annualized is required to reach the 5-10x target, even with periods of significant drawdowns and bull cases. Obviously stock selection and staying invested for the long term are key.
My initial tentative selection of 10 stocks NVDA, ASML, MSFT, AVGO, NBIS, GOOG, TSLA, CCO, NVO, and SHOP with weightings ranging from 6% to 16%
Could you please critique my strategy and the stocks selected. Suggest improvements including alternative names to consider as replacements that you feel might work better.
If you were creating such a portfolio for yourself which 10 names would you select.
-
Eli Lilly and Company (LLY $978.98)
- $978.98 P/E (TTM): 41.98X Cap: $911.53B
- View LLY Profile
- View Questions on LLY
-
Novo Nordisk A/S (NVO $44.27)
- $44.27 P/E (TTM): 12.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
Vanguard Health Care ETF (VHT $271.56)
- $271.56 P/E (TTM): 24.74X Cap: $17.65B
- View VHT Profile
- View Questions on VHT
-
iShares U.S. Healthcare ETF (IYH $61.03)
- $61.03 P/E (TTM): 24.16X Cap: $2.78B
- View IYH Profile
- View Questions on IYH
Q: I have a > 50% loss on NVO in an RSP, so I'm unable to harvest the tax loss. Do you feel I would break even faster if I, held, sold and bought a US dollar health ETF or LLY? I'm starting to think healthcare ETF, as if I pick the wrong horse, I can end up in the same situation again. What are your recommendations? Healthcare fits in best for my portfolio weightings.
Thanks
Thanks
-
Novo Nordisk A/S (NVO $44.27)
- $44.27 P/E (TTM): 12.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Q: A very unfortunate investment that I was hoping would turn a little before I dump it. Down 53%……is there any point in waiting for improvement.
Len
Len
Insiders
Share Information
SEC Filings
News and Media